Literature DB >> 25179734

Transient abnormal myelopoiesis/acute megakaryoblastic leukemia diagnosed in the placenta of a stillborn Down syndrome fetus with targeted next-generation sequencing.

B Federmann1, A Fasan2, K O Kagan3, S Haen1, F Fend1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25179734     DOI： 10.1038/leu.2014.258

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

Review 1.  Down's syndrome.

Authors:  Nancy J Roizen; David Patterson
Journal:  Lancet       Date:  2003-04-12       Impact factor: 79.321

Review 2.  Transient leukaemia--a benign form of leukaemia in newborn infants with trisomy 21.

Authors:  Alvin Zipursky
Journal:  Br J Haematol       Date:  2003-03       Impact factor: 6.998

3.  Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.

Authors:  H Hasle; J Abrahamsson; M Arola; A Karow; A O'Marcaigh; D Reinhardt; D K H Webb; E van Wering; B Zeller; C M Zwaan; P Vyas
Journal:  Leukemia       Date:  2007-12-06       Impact factor: 11.528

4.  Risks of leukaemia and solid tumours in individuals with Down's syndrome.

Authors:  H Hasle; I H Clemmensen; M Mikkelsen
Journal:  Lancet       Date:  2000-01-15       Impact factor: 79.321

5.  GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.

Authors:  Johann K Hitzler; Joseph Cheung; Yue Li; Stephen W Scherer; Alvin Zipursky
Journal:  Blood       Date:  2003-02-13       Impact factor: 22.113

6.  Morphologic and GATA1 sequencing analysis of hematopoiesis in fetuses with trisomy 21.

Authors:  Sylvia Hoeller; Michel P Bihl; Alexandar Tzankov; Rosemarie Chaffard; Petra Hirschmann; Peter Miny; Thomas Kühne; Elisabeth Bruder
Journal:  Hum Pathol       Date:  2014-01-17       Impact factor: 3.466

7.  Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.

Authors:  Brandie Heald; Joanne M Hilden; Kevin Zbuk; Alice Norton; Paresh Vyas; Karl S Theil; Charis Eng
Journal:  Nat Clin Pract Oncol       Date:  2007-07

Review 8.  Prenatal diagnosis of congenital leukemia in a fetus at 25 weeks' gestation with Down syndrome: case report and review of the literature.

Authors:  M Robertson; G De Jong; E Mansvelt
Journal:  Ultrasound Obstet Gynecol       Date:  2003-05       Impact factor: 7.299

9.  Treatment and prognostic impact of transient leukemia in neonates with Down syndrome.

Authors:  Jan-Henning Klusmann; Ursula Creutzig; Martin Zimmermann; Michael Dworzak; Norbert Jorch; Claudia Langebrake; Arnulf Pekrun; Katarina Macakova-Reinhardt; Dirk Reinhardt
Journal:  Blood       Date:  2008-01-08       Impact factor: 22.113

10.  GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.

Authors:  Irene Roberts; Kate Alford; Georgina Hall; Gaetan Juban; Helen Richmond; Alice Norton; Grant Vallance; Kelly Perkins; Emanuele Marchi; Simon McGowan; Anindita Roy; Gillian Cowan; Mark Anthony; Amit Gupta; John Ho; Sabita Uthaya; Anna Curley; Shree Vishna Rasiah; Timothy Watts; Richard Nicholl; Alison Bedford-Russell; Raoul Blumberg; Angela Thomas; Brenda Gibson; Chris Halsey; Pek-Wan Lee; Sunit Godambe; Connor Sweeney; Neha Bhatnagar; Anne Goriely; Peter Campbell; Paresh Vyas
Journal:  Blood       Date:  2013-09-10       Impact factor: 25.476
View more
  1 in total

1.  Myeloid cell thrombus and fetal vascular malperfusion in placentas with transient abnormal myelopoiesis.

Authors:  Kayo Tomimori; Yuki Kodama; Hiroyuki Tanaka; Atushi Yamashita; Toshihiro Gi; Yujiro Asada; Koutarou Doi; Shinji Katsuragi; Yuichiro Sato
Journal:  Virchows Arch       Date:  2022-02-24       Impact factor: 4.064
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.